Beck Capital Management »

Ishares Tr genomics immun shares owned by Beck Capital Management

Quarter-by-quarter ownership of Ishares Tr genomics immun (IDNA) shares owned by Beck Capital Management from 13F filings

Historical chart of Beck Capital Management investment in Ishares Tr genomics immun

Tip: Access up to 7 years of quarterly data

All positions including Ishares Tr genomics immun held by Beck Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ishares Tr genomics immun by Beck Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $336k 10k 33.75

More positions owned by Beck Capital Management

Micron Technology (MU)
NVIDIA Corporation (NVDA)
Vertiv Holdings Com Cl A (VRT)
Ge Vernova (GEV)
Broadcom (AVGO)
Sandisk Corp (SNDK)
Corning Incorporated (GLW)
Ftai Aviation SHS (FTAI)
Cameco Corporation (CCJ)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Palo Alto Networks (PANW)
Western Digital (WDC)
Amazon (AMZN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)

View all positions for Beck Capital Management

Top funds holding Ishares Tr genomics immun

UBS Group
Bank of America Corporation
Wharton Business Group
Jane Street
Ameriprise Financial
Portland Global Advisors
Wells Fargo & Company
Morgan Stanley
BCJ Capital Management
Royal Bank of Canada
Raymond James Financial
LPL Financial
Lido Advisors
Nelson, Van Denburg & Campbell Wealth Management
Bsc Private Wealth Management

View all funds holding Ishares Tr genomics immun